AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Trends Analyst Outlook Journalist POV

76 hedge funds and large institutions have $286M invested in Avadel Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $86K

Holders
76
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$86K
Net Calls
Net Calls Change

Top Buyers

1
+$3.39M
2
+$3.13M
3
+$2.37M
4
HA
Heartland Advisors
Wisconsin
+$1.17M
5
Morgan Stanley
Morgan Stanley
New York
+$1.13M

Top Sellers

1
-$10.2M
2
-$4.96M
3
-$4.76M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$4.68M
5
Asset Management One
Asset Management One
Japan
-$2.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
76
–
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
1 2 3
4